Title |
Efficiency and Safety of Baofei Granules in Chronic Obstructive Pulmonary Disease (Lung and Spleen Qi Deficiency Syndrome): A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase II Clinical Trial
|
---|---|
Published in |
Drug Design, Development and Therapy, December 2022
|
DOI | 10.2147/dddt.s382285 |
Pubmed ID | |
Authors |
Yuan Sun, Xuan Chen, Lei Zhang, Wei-an Yuan, Qi Chen, Yi-bao Zhang, Lu-jiong Liu, Wei Zhang, Meng Sun |
X Demographics
The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 2 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 2 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 22 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 22 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Unspecified | 2 | 9% |
Other | 2 | 9% |
Student > Master | 2 | 9% |
Researcher | 2 | 9% |
Student > Doctoral Student | 1 | 5% |
Other | 2 | 9% |
Unknown | 11 | 50% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 5 | 23% |
Unspecified | 2 | 9% |
Nursing and Health Professions | 2 | 9% |
Sports and Recreations | 1 | 5% |
Biochemistry, Genetics and Molecular Biology | 1 | 5% |
Other | 0 | 0% |
Unknown | 11 | 50% |
Attention Score in Context
This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 31 December 2022.
All research outputs
#16,922,633
of 25,658,541 outputs
Outputs from Drug Design, Development and Therapy
#1,025
of 2,276 outputs
Outputs of similar age
#262,724
of 490,560 outputs
Outputs of similar age from Drug Design, Development and Therapy
#7
of 31 outputs
Altmetric has tracked 25,658,541 research outputs across all sources so far. This one is in the 32nd percentile – i.e., 32% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,276 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 7.2. This one has gotten more attention than average, scoring higher than 50% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 490,560 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 43rd percentile – i.e., 43% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 31 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 70% of its contemporaries.